Sign in Pull a receipt

COCP

Cocrystal Pharma, Inc.

Healthcare · Biotechnology

$135.58 sample

+2.16 (+1.62%) 1D

Market cap

$390.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$135.58 +0.39% 3M daily closessample

140.30129.10

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SECForm 144 filed
Oct 22INSInsider buy: Chief Executive Officer
Oct 16SEC8-K filed: material event
Oct 09INSInsider buy: Chief Executive Officer
Sep 30SECDEF 14A filed
Sep 22INSInsider buy: 10% owner
Sep 17SECDEF 14A filed
Sep 09SEC10-Q filed

Sign up to see the real COCP record →

Company facts

SEC EDGAR registration

Name: Cocrystal Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +48sample, -100 to +100
Reporting currency: USD

Who is positioning in COCP

sample

Insiders: 8 insider transactions over 90 days, net selling, $824.1M
Congress: No member trades over 90 days
Institutions · 13F: 12 funds hold $7.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.4B +11.9% y/y

Q4 2024Q3 2026

Inventory$11.3B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$8.7B +8.8% y/y

Q4 2024Q3 2026

Total debt$23.5B +10.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $324.3B +14.8% 3M
Sample peer B: $221.2B -12.3% 3M
Sample peer C: $50.5B +12.4% 3M
Sample peer D: $173.7B -2.6% 3M
Sample peer E: $250.7B -1.2% 3M